[144] MapLight Therapeutics, Inc. SEC Filing

Maplight Therapeutics, Inc. submitted a Form 144 notice listing 52,428 shares of common stock associated with a broker-dealer, Jefferies LLC, and showing an aggregate figure of $1,609,539.60.

Rhea-AI Filing Summary

Maplight Therapeutics, Inc. submitted a Form 144 notice listing 52,428 shares of common stock associated with a broker-dealer, Jefferies LLC, and showing an aggregate figure of $1,609,539.60. The filing lists prior sales by James Lillie of 1,730 and 2,783 shares on 04/15/2026 and 04/16/2026, respectively.

Insights

Securities Compliance Analyst

Rule 144 notice records an intended resale of registered shares and recent open-market dispositions.

The filing lists 52,428 shares of common stock routed through Jefferies LLC and an aggregate amount of $1,609,539.60. It also documents two prior sales by James Lillie of 1,730 and 2,783 shares on 04/15/2026 and 04/16/2026

Rule 144 notices are administrative disclosures required for restricted or control securities; cash‑flow treatment and timing of any resale are not stated in the excerpt. Subsequent filings would show execution details or confirmations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Maplight Therapeutics' (MPLT) Form 144 disclose?

The Form 144 discloses 52,428 shares of common stock linked to Jefferies LLC and an aggregate figure of $1,609,539.60. It also lists two prior sales by James Lillie on 04/15/2026 and 04/16/2026.

Who is the broker listed on MPLT's Form 144?

The broker-dealer named is Jefferies LLC at 520 Madison Ave, New York. The filing ties the broker to the listed 52,428 shares and the attendant transaction disclosure.

What sales by insiders does the Form 144 show for MPLT?

The filing shows James Lillie sold 1,730 shares on 04/15/2026 for $46,398.27 and 2,783 shares on 04/16/2026 for $76,175.44. These are recorded prior dispositions.

Does the Form 144 show when the listed shares will be sold?

The excerpt lists the quantity (52,428 shares) and the broker but does not state the execution timing or methods. Timing and execution details are not provided in the provided text.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/04/2026 - 05:20 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001728746
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	MapLight Therapeutics, Inc.
SEC File Number	001-42914
Address of Issuer	800 CHESAPEAKE DRIVE REDWOOD CITY CALIFORNIA 94063
Phone	650-839-4360
Name of Person for Whose Account the Securities are To Be Sold	Lillie James Woodruff
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Jefferies LLC 520 Madison Ave 4th Fl New York NY 10022	52428	1609539.60	42000000	05/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/05/2024	Vested RSU	Maplight Therapeutics, Inc.			52428	07/05/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James Lillie 800 Chesapeake Drive Redwood City CA 94063	Maplight Therapeutics, Inc.	04/15/2026	1730	46398.27
James Lillie 800 Chesapeake Drive Redwood City CA 94063	Maplight Therapeutics, Inc.	04/16/2026	2783	76175.44

144: Remarks and Signature

Remarks	All Sales are to be made pursuant to a previously signed/adopted 10b5-1 Selling plan dated 12/29/2025, and all representations regarding material non-public information were made as of the adoption of the plan. The securities to be sold were acquired upon the vesting of restricted stock units during the period of 07/05/2024 through 04/01/2026.
Date of Notice	05/04/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/29/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	James Lillie
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)